NEW YORK, Oct. 9 – PerkinElmer CEO Gregory L. Summe said on Tuesday that his company is on track to close its proposed acquisition of Packard BioScience in November.

Speaking at the UBS Warburg Global Life Sciences Conference, which runs here through the end of the week, Summe, who is also PerkinElmer’s chairman, said all that remains is a final formal approval by the Securities and Exchange Commission.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.